RS BioTherapeutics is a research, development, and commercialization company focused on pulminary diseases.
RS BioTherapeutics has raised $195K in total funding. The most recent round was Equity Crowdfunding. The last funding was announced in July 2024.
RS BioTherapeutics is headquartered in Cumberland, United States.
RS BioTherapeutics is a research, development, and commercialization company focused on pulminary diseases.
RS BioTherapeutics is at the Equity Crowdfunding stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"RS BioTherapeutics — Funding & Investors." VCBacked, July 30, 2024, https://www.vcbacked.co/company/rs-biotherapeutics. Accessed September 30, 2026.
VCBacked. (2024). RS BioTherapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/rs-biotherapeutics
{{cite web |title=RS BioTherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/rs-biotherapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated